Cell Line : HEC-1-A
Cellosaurus Index : CVCL_0293
Cellosaurus ID : HEC-1-A
CCLE Name
: HEC1A_ENDOMETRIUM
CTRP2 Name
: HEC1A
Cancer Type : endometrium
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| HEC-1-A | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| HEC-1-A | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| HEC-1-A | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| HEC-1-A | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | bafilomycin A1 | CTRP2 | 0.0000 | 0.3300 |
|
| HEC-1-A | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| HEC-1-A | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| HEC-1-A | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K01737880 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | BRD-K04800985 | CTRP2 | 0.0020 | 67.0000 |
|
| HEC-1-A | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K13999467 | CTRP2 | 0.0020 | 67.0000 |
|
| HEC-1-A | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K17060750 | CTRP2 | 0.0020 | 67.0000 |
|
| HEC-1-A | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| HEC-1-A | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K30748066 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K33199242 | CTRP2 | 0.0020 | 67.0000 |
|
| HEC-1-A | BRD-K33514849 | CTRP2 | 0.0010 | 34.0000 |
|
| HEC-1-A | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| HEC-1-A | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD-K41597374 | CTRP2 | 0.0020 | 67.0000 |
|
| HEC-1-A | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K63431240 | CTRP2 | 0.0009 | 30.0000 |
|
| HEC-1-A | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| HEC-1-A | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| HEC-1-A | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| HEC-1-A | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | BRD9876:MK-1775 (4:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 48.0000 |
|
| HEC-1-A | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| HEC-1-A | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| HEC-1-A | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| HEC-1-A | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Crizotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-1-A | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-1-A | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| HEC-1-A | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| HEC-1-A | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| HEC-1-A | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| HEC-1-A | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| HEC-1-A | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| HEC-1-A | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | GSK-J4 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | hyperforin | CTRP2 | 0.0020 | 33.0000 |
|
| HEC-1-A | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| HEC-1-A | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-1-A | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-1-A | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-1-A | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| HEC-1-A | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| HEC-1-A | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | lovastatin acid | CTRP2 | 0.0041 | 66.0000 |
|
| HEC-1-A | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| HEC-1-A | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | MIRA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| HEC-1-A | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| HEC-1-A | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| HEC-1-A | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HEC-1-A | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| HEC-1-A | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Nilotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| HEC-1-A | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| HEC-1-A | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| HEC-1-A | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Nutlin-3a | CTRP2,CCLE | 0.0025 | 150.0000 |
|
| HEC-1-A | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| HEC-1-A | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | Palbociclib | CCLE | 0.0025 | 8.0000 |
|
| HEC-1-A | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| HEC-1-A | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| HEC-1-A | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| HEC-1-A | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| HEC-1-A | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| HEC-1-A | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| HEC-1-A | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| HEC-1-A | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-1-A | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| HEC-1-A | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| HEC-1-A | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| HEC-1-A | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| HEC-1-A | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| HEC-1-A | Selumetinib | CTRP2,CCLE | 0.0025 | 270.0000 |
|
| HEC-1-A | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-1-A | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-1-A | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-1-A | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-1-A | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HEC-1-A | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HEC-1-A | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HEC-1-A | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HEC-1-A | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| HEC-1-A | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HEC-1-A | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HEC-1-A | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| HEC-1-A | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| HEC-1-A | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| HEC-1-A | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-1-A | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| HEC-1-A | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SNX-2112 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-1-A | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SR8278 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| HEC-1-A | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| HEC-1-A | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Tanespimycin | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| HEC-1-A | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HEC-1-A | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| HEC-1-A | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HEC-1-A | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| HEC-1-A | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| HEC-1-A | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| HEC-1-A | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| HEC-1-A | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| HEC-1-A | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| HEC-1-A | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| HEC-1-A | Vincristine | CTRP2 | 0.0081 | 130.0000 |
|
| HEC-1-A | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | VX-680 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| HEC-1-A | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| HEC-1-A | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| HEC-1-A | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| HEC-1-A | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC